Innate Lymphoid Cells in Inflammatory Bowel Disease
Cells · 02.06.2025 · 14 (11) · 825
DOI: 10.3390/cells14110825 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 02.06.2025. Verfasst von Xin Yao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: Immunity, Innate, Inflammatory Bowel Diseases, Lymphocytes. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 231 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NIH/NIDDK K08 Clinical Investigator Award.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a chronic inflammatory disorder of the gastrointestinal tract with rising incidence and an unclear etiology. Innate lymphoid cells (ILCs) have recently emerged as key regulators of mucosal immunity and tissue homeostasis and are increasingly implicated in IBD. Unlike adaptive lymphocytes, ILCs do not require antigen recognition and clonal expansion to respond rapidly to environmental cues and shape immune responses. In a healthy gut, ILCs maintain intestinal homeostasis by guarding the epithelial barrier, protecting against pathogens, and mounting proper responses to external insults. However, their altered differentiation, proliferation, recruitment, activation, and interaction with other host cells, microbiota, and environmental stimuli may contribute to IBD. In this review, we discuss recent advances in understanding murine and human ILCs in the context of intestinal inflammation and IBD. A deeper understanding of ILC-mediated immune mechanisms may offer novel therapeutic strategies for restoring intestinal homeostasis and improving personalized management of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO 63110, USA.
ORCID-Profile: Xin Yao, Yangzhuangzhuang Zhu, Siyan Cao
Förderung
- NIDDK NIH HHS
- NIH HHS
- NIH/NIDDK K08 Clinical Investigator Award
- Crohn’s and Colitis Foundation Career Development Award
- American Gastroenterological Association Fellowship-to-Faculty Transition Award
- Pilot Research Award
- American College of Gastroenterology Clinical Research Award
- Lawrence C. Pakula, MD IBD Research Innovator Award
Zitieren
APA
Yao, X., Ma, K., Zhu, Y., & Cao, S. (2025). Innate Lymphoid Cells in Inflammatory Bowel Disease. Cells, 14(11), 825. https://doi.org/10.3390/cells14110825
Vancouver
Yao X, Ma K, Zhu Y, Cao S. Innate Lymphoid Cells in Inflammatory Bowel Disease. Cells. 2025;14(11):825. doi:10.3390/cells14110825
BibTeX
@article{Yao2025,
author = {Yao, Xin and Ma, Kaiming and Zhu, Yangzhuangzhuang and Cao, Siyan},
title = {Innate Lymphoid Cells in Inflammatory Bowel Disease},
journal = {Cells},
year = {2025},
volume = {14},
number = {11},
pages = {825},
doi = {10.3390/cells14110825}
}
EUVIMED